Clinical trial
A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma
NCT00455091 · National Health Research Institutes, Taiwan, Other · Terminated
Key facts
| NCT number | NCT00455091 |
|---|---|
| Title | A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma |
| Official title | A Randomization Trial of Adjuvant Lamivudine/ Adefovir Dipivoxil Against Recurrence in Post-operative HBV-related Hepatocellular Carcinoma |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | National Taiwan University Hospital Chang Gung Memorial Hospital Taipei Veterans General Hospital, Taiwan Mackay Memorial Hospital Taichung Veterans General Hospital Changhua Christian Hospital… |
| Status | Terminated |
| Study type | Observational |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | Adefovir Dipivoxil and Lamivudine |
| Enrollment | 117 |
| Start date | May 1, 2007 |
| Primary completion | Apr 1, 2012 |
| Completion | Apr 1, 2018 |
| First posted | Apr 3, 2007 |
| Last update posted | Apr 28, 2017 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: